Wu Mei Wan (Mume Pill)

Actions

Indications

Western Uses:

• What is Wu Mei Wan used for in modern practice?

  In modern practice, Wu Mei Wan is traditionally associated with biliary ascariasis and with chronic, mixed-pattern colitis-type conditions. Its classic hui jue presentation — paroxysmal epigastric or right-upper-quadrant colicky pain with vomiting and cold extremities — corresponds to what Western medicine recognizes as roundworms migrating into and irritating the bile duct. Separately, its chronic-diarrhea application has drawn contemporary interest for patterns resembling ulcerative colitis, irritable bowel syndrome, and other chronic digestive conditions with a mixed cold-heat, deficiency-and-excess quality.

  These biomedical correlates are offered as a reference to the formula’s traditional use, not as a claim that it treats any diagnosed disease. Confirmed biliary obstruction, cholangitis, or pancreatitis from ascariasis is a medical emergency requiring conventional care; any use of this formula for a diagnosed digestive condition belongs with a qualified practitioner alongside appropriate medical management (see research and cautions).

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies, and Chen & Chen, Chinese Herbal Formulas and Applications; reference only, not a treatment claim.

Originally Appeared In:

• On Cold Damage (Shang Han Lun)

Notes:

• How is Wu Mei Wan different from other cold-heat-complex or antiparasitic formulas?

  Wu Mei Wan is distinguished by combining all three of the classical worm-calming flavors — sour, bitter, and acrid — with qi-and-blood tonification, rather than relying on purgation or a single warming or clearing strategy. This is what separates it from simpler antiparasitic or diarrhea formulas.

  • vs Gan Jiang Huang Qin Huang Lian Ren Shen Tang (another Shang Han Lun cold-heat-complex formula, for vomiting and diarrhea from cold below/heat above): that formula clears and warms without Wu Mei Wan’s astringent, worm-calming sour component or its Xi Xin/Chuan Jiao/Gui Zhi warming trio, and does not target roundworm disorder.
  • vs simple anthelmintic (worm-expelling) formulas (e.g., those built around Bing Lang and Shi Jun Zi/Quisqualis): those purge and expel worms directly; Wu Mei Wan instead “calms” (an) the worms and addresses the underlying cold-heat complex and deficiency, and is the formula of choice when the roundworm has caused acute biliary colic (hui jue) rather than routine intestinal infestation.
  • vs Li Zhong Wan (warms the Spleen/Stomach middle alone): Li Zhong Wan has no clearing or astringing component and does not address a mixed cold-heat presentation or roundworms.

  Key modifications: for acute biliary colic, Bing Lang and Ku Lian Gen Pi (Chinaberry root-bark) are commonly added to more directly expel roundworms; where heat signs dominate, the doses of Fu Zi, Gan Jiang, Chuan Jiao, and Xi Xin are reduced; where cold signs dominate, Huang Lian and Huang Bai are reduced; for chronic diarrhea without roundworm involvement, Chuan Jiao and Xi Xin are often reduced or omitted while the astringing, warming-tonifying core is retained.

  Source: Bensky & Barolet, Formulas & Strategies; Chen & Chen, Chinese Herbal Formulas and Applications (comparisons and modifications).

Clinical Studies & Research:

• Is there modern research on Wu Mei Wan?

  Yes — research clusters around chronic digestive/inflammatory bowel conditions, particularly ulcerative colitis, spanning a clinical meta-analysis and preclinical mechanism studies. A meta-analysis of randomized controlled trials found Wumei Bolus (Wu Mei Wan) combined with conventional treatment more effective than conventional treatment alone for ulcerative colitis, with fewer adverse reactions and reduced inflammatory markers. Mechanistic studies in animal models point to effects on intestinal immune regulation and mucosal barrier repair.

  • Ulcerative colitis (clinical meta-analysis): 37 RCTs (3,145 patients) found Wumei Bolus plus conventional therapy more effective than conventional therapy alone (RR 1.24), with lower adverse-reaction rates and reduced TNF-α and IL-8 (PMID 37180938).
  • Ulcerative colitis (preclinical mechanism): in DSS-induced colitis mice, Wu-Mei-Wan ameliorated colitis by shifting macrophage polarization from pro-inflammatory M1 toward anti-inflammatory M2 via p38MAPK, NF-κB, and STAT6 signaling (PMID 35387334).
  • Chronic digestive disease (network pharmacology): a network-pharmacology and molecular-docking analysis proposed shared mechanisms by which Wumei Pills may act across ulcerative colitis, diabetic enteropathy, and irritable bowel syndrome — an example of the classical “treating different diseases with the same method” principle (PMID 36046907).

  Sources: PubMed 37180938; PubMed 35387334; PubMed 36046907. Research context, not a therapeutic claim; direct clinical evidence for the formula’s classical roundworm/hui jue indication remains a matter of historical and case-based record rather than modern trials.